IPRO2 CGM SYSTEM WITH ENLITE SENSOR

Sensor, Glucose, Invasive

FDA Premarket Approval P150029

This medical device has supplements. The device description/function or indication may have changed. Be sure to look at the supplements to get an up-to-date information on device changes. The labeling included below is the version at time of approval of the original pma or panel track supplement and may not represent the most recent labeling.

Pre-market Approval Supplement Details

Approval for the ipro2 system. This device is indicated for:the ipro2 recorder is to be used with either enlite sensor or sof-sensor and is intended to continuously record interstitial glucose levels in persons with diabetes mellitus. This information is intended to supplement, not replace, blood glucose information obtained using a standard home glucose-monitoring device. The information collected by the ipro2 recorder may be uploaded to a computer (with internet access) and reviewed by healthcare professionals. This information may allow identification of patterns of glucose level excursions above or below the desired range, facilitating therapy adjustments which may minimize these excursions. The ipro2 system:1) is intended for prescription use only;2) does not allow data to be made available directly to patients in real time;3) provides data that will be available for review by physicians after the recording interval (up to 144 hours);4) is intended for occasional rather than everyday use; and5) is to be used only as a supplement, and not a replacement for, standard invasive measurement.

DeviceIPRO2 CGM SYSTEM WITH ENLITE SENSOR
Classification NameSensor, Glucose, Invasive
Generic NameSensor, Glucose, Invasive
ApplicantMEDTRONIC MINIMED
Date Received2015-08-10
Decision Date2016-06-17
Notice Date2016-06-24
PMAP150029
SupplementS
Product CodeMDS
Docket Number16m-1755
Advisory CommitteeClinical Chemistry
Expedited ReviewNo
Combination Product No
Applicant Address MEDTRONIC MINIMED 18000 Devonshire St northridge, CA 91325
Summary:Summary of Safety and Effectiveness
Labeling: Labeling
Approval Order: Approval Order

Supplemental Filings

Supplement NumberDateSupplement Type
P150029Original Filing
S038 2022-04-01 30-day Notice
S037 2021-11-17 Special (immediate Track)
S036 2021-01-27 Special (immediate Track)
S035 2020-11-03 30-day Notice
S034 2019-11-29 30-day Notice
S033 2019-10-17 30-day Notice
S032
S031 2019-08-21 30-day Notice
S030 2019-07-15 30-day Notice
S029 2019-06-19 30-day Notice
S028
S027 2019-02-11 30-day Notice
S026 2019-02-01 30-day Notice
S025 2018-11-07 30-day Notice
S024 2018-11-07 30-day Notice
S023 2018-11-02 30-day Notice
S022 2018-10-15 30-day Notice
S021 2018-07-09 30-day Notice
S020 2018-06-19 30-day Notice
S019 2018-06-07 Special (immediate Track)
S018 2018-03-26 30-day Notice
S017 2018-03-12 30-day Notice
S016 2018-02-09 Real-time Process
S015 2018-02-07 30-day Notice
S014 2017-12-22 30-day Notice
S013 2017-11-24 30-day Notice
S012 2017-10-30 30-day Notice
S011 2017-07-17 30-day Notice
S010 2017-06-22 Real-time Process
S009 2017-05-30 30-day Notice
S008 2017-03-31 30-day Notice
S007
S006 2016-12-23 Real-time Process
S005 2016-12-12 30-day Notice
S004 2016-11-28 30-day Notice
S003 2016-11-28 30-day Notice
S002 2016-11-02 30-day Notice
S001 2016-07-21 30-day Notice

NIH GUDID Devices

Device IDPMASupp
00763000049492 P150029 000
00643169938076 P150029 010
00763000049997 P150029 010
00763000049492 P150029 010

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.